Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Orpathys approved in China for patients with lung cancer and MET gene alterations
-
Koselugo approved in the EU for children with neurofibromatosis type 1 and plexiform neurofibromas
-
AstraZeneca welcomes Court ruling on supply of its COVID-19 vaccine to Europe
-
COVID-19 Vaccine AstraZeneca effective against Delta (‘Indian’) variant
-
Update on AZD7442 STORM CHASER trial in post-exposure prevention of symptomatic COVID-19
-
Calquence demonstrated fewer incidences of atrial fibrillation versus ibrutinib in previously treated patients with chronic lymphocytic leukaemia and sustained patient benefit at four years in the front-line setting
-
AstraZeneca appoints Aradhana Sarin as new Chief Financial Officer
-
Imfinzi demonstrated unprecedented survival in unresectable, Stage III lung cancer with 43% of patients surviving five years
-
Lynparza reduced the risk of cancer recurrence by 42% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer in OlympiA Phase III trial
-
Anifrolumab showed benefit across different measures of skin and joint disease activity in patients with systemic lupus erythematosus
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
